Literature DB >> 34118868

Serum pepsinogen levels in different regions of China and its influencing factors: a multicenter cross-sectional study.

Yuling Tong1, Hongguang Wang2, Yi Zhao1, Xueqiang He3, Hongwei Xu4, Hong Li5, Ping Shuai6, Lirong Gong6, Hongbo Wu7, Hongzhi Xu8, Yinhu Luo9, Dong Wang10, Shizhu Liu2, Zhenya Song11.   

Abstract

BACKGROUND: The aim of this study is to investigate the difference of serum pepsinogen (PG) baseline levels in different regions of China and its influencing factors.
METHODS: From October 2016 to October 2018, asymptomatic health checkup people who underwent nasal endoscopy in nine health management centers in different regions of China were collected. Lifestyle questionnaires were conducted, and serum PG and gastroscopy were performed. The differences in PG levels in baseline population (OLGA-0 grade) were studied according to geographical subregions of China. SPSS software was used for statistical analysis.
RESULTS: 1922 patients were included in the final analysis. Compared with the non-atrophy (OLGA-0) group, PGR levels in atrophy group (OLGA-I to IV) were significantly decreased with the atrophy degree (p < 0.05). A total of 1590 baseline people (OLGA-0) were included in the study, including 254 from South China, 574 from East China, 210 from Southwest China, 332 from Northeast China, and 220 from Central/Northern China. There were significant differences in baseline PGI levels among the five regions (p < 0.05). The PGII levels were also different among the five regions, except for Central/Northern versus Southern China. PGR (PGI/PGII ratio) levels in Southern China were higher than other four regions. Further studies were conducted on the related factors that might affect the baseline PG level, which was affected by nationality, dietary habits, smoking, Helicobacter pylori infection and other related factors.
CONCLUSION: Influenced by many factors, the baseline PG levels are different in different regions of China. In the follow-up studies of PG cut-off value, different PG cut-off value based on region may be more effective in the screening of gastric cancer and precancerous lesions in China.

Entities:  

Keywords:  Baseline survey; Different regions of China; Influencing factors; Serum pepsinogen

Year:  2021        PMID: 34118868     DOI: 10.1186/s12876-021-01794-6

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  3 in total

1.  Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study.

Authors:  M Rugge; M de Boni; G Pennelli; M de Bona; L Giacomelli; M Fassan; D Basso; M Plebani; D Y Graham
Journal:  Aliment Pharmacol Ther       Date:  2010-02-23       Impact factor: 8.171

2.  Helicobacter pylori eradication for the prevention of gastric neoplasia.

Authors:  Alexander C Ford; Yuhong Yuan; David Forman; Richard Hunt; Paul Moayyedi
Journal:  Cochrane Database Syst Rev       Date:  2020-07-06

3.  Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population.

Authors:  Abbas Zoalfaghari; Najmeh Aletaha; Nader Roushan; Reza Taslimi; Hossein Foroutan; Bita Faridnia
Journal:  Med J Islam Repub Iran       Date:  2014-12-16
  3 in total
  3 in total

1.  Preliminary Study on Reference Interval of Serum Pepsinogen in Healthy Subjects.

Authors:  Liang Zhang; Ye Niu; Yin-Jiang Lv; Li-Feng Wu; Qi-Lei Hu; Rong Huang; Ru-Jin Xu
Journal:  Patient Prefer Adherence       Date:  2021-12-09       Impact factor: 2.711

2.  Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study.

Authors:  Danute Razuka-Ebela; Inese Polaka; Ilva Daugule; Sergei Parshutin; Daiga Santare; Inguna Ebela; Dace Rudzite; Reinis Vangravs; Rolando Herrero; Jin Young Park; Marcis Leja
Journal:  Diagnostics (Basel)       Date:  2022-05-07

Review 3.  Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening to Helicobacter pylori Eradication in Korea.

Authors:  Young-Il Kim; Il Ju Choi
Journal:  J Gastric Cancer       Date:  2022-07       Impact factor: 3.197

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.